Physician profile
Barbara Ahern
NPI 1568974970
$746.86
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.94 · 2022: $158 · 2023: $393 · 2024: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $94.52 | 2023 | |
| Astellas Pharma US INC | $87.03 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $78.30 | 2022-2024 | Austedo Xr, Austedo |
| Avanir Pharmaceuticals, INC. | $72.75 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $70.32 | 2023 | Verquvo |
| Lilly USA, LLC | $62.16 | 2022-2023 | Trulicity, Humalog, Baqsimi |
| Otsuka America Pharmaceutical, INC. | $60.49 | 2023-2024 | Rexulti, Nuedexta |
| Cmp Pharma, INC. | $42.85 | 2022-2023 | Carospir, Norliqva, Tadliq |
| Neurelis, INC. | $34.79 | 2023-2024 | Valtoco |
| Abbvie INC. | $29.75 | 2024 | |
| Eisai INC. | $15.56 | 2024 | |
| Sumitomo Pharma America, INC. | $14.88 | 2023 | Gemtesa |
| Sunovion Pharmaceuticals INC. | $14.77 | 2021 | |
| Nestle Healthcare Nutrition INC. | $14.46 | 2023 | |
| Scilex Pharmaceuticals INC. | $14.26 | 2023 | Ztlido |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $13.52 | 2023 | Wakix |
| Pulmonx Corporation | $13.50 | 2024 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Abbott Laboratories | $12.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Ahern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.